Affidea

Healthcare systems are balancing rising imaging demand, increasing subspecialisation and workforce pressures, while operating within complex regulatory, financial and cross-border environments. For those reasons, Biotronics3D believes legacy on-premise imaging infrastructure is no longer sufficient to support the flexibility and resilience that modern European healthcare requires. Instead, the company sees cloud-native imaging as a practical and […]

Affidea has opened its flagship neuraCare Centre in Athens, Greece, marking the first step in a planned rollout of a European network of centres of excellence in neurology. The provider of advanced diagnostics and community-based polyclinics says it is responding to the need for more integrated, innovative and patient-focused care, as the number of some […]

Radiology is under pressure: rising imaging volumes, workforce shortages and increasing complexity in breast cancer care are forcing providers to rethink how work gets done. To address this challenge, Affidea, in collaboration with Biotronics3D and b-rayZ have joined forces to deliver an integrated mammography AI solution inside a PACS/RIS environment with the scope of streamlining […]

Provider of advanced diagnostics and outpatient services Affidea Group is accelerating its UK expansion through AM Diagnostic Services (AMDS), its dedicated imaging and diagnostic staffing division. Leveraging Affidea’s European network and investment, AMDS delivers scalable, clinically-led solutions across multiple imaging modalities to NHS and independent healthcare providers. CQC-registered AMDS specialises in deploying cross-trained, skilled clinical […]

In today’s complex healthcare environment, the need for fast, accurate, and accessible diagnostic services has never been greater. From early disease detection to guiding long-term clinical decisions, diagnostics form the backbone of modern medicine. At the forefront of this mission is AM Diagnostic Services (AMDS), a trusted provider of imaging and diagnostic staffing solutions across […]

European provider of advanced diagnostics, outpatient and cancer care services Affidea has been awarded ‘Diagnostics provider of the year’ at the 2022 Health Investors Awards. These awards recognise outstanding achievements, innovation and excellence in the independent healthcare sector and aim to reward organisations that have made a significant contribution in the medical sector. Affidea was praised […]

Affidea Group has acquired the Tecma clinic, an outpatient medical provider in Valencia, Spain. Tecma carries out more than 300,000 visits a year, offering advanced diagnostic imaging. With this acquisition in Spain, Affidea will reach 37 centres, serving more than 500,000 patients every year and expanding its geographical footprint. At country level, Affidea is working […]

Provider of diagnostic imaging, outpatient and cancer care services Affidea Group has completed the acquisition of a majority stake in Brust-Zentrum Zürich, a large integrated breast medicine group in Switzerland. Brust-Zentrum Zürich offers integrated services in women’s health such as breast cancer screening, diagnostic imaging, outpatient consultations, oncological medication treatment and surgical treatment. It has […]